对ATP的RNA干扰作为前列腺癌的基因治疗方法
Shuangya Chen1, Jisheng Ma1, Yunbei Xiao2
1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325030, China.
Molecular pharmaceutics
|September 21, 2023
概括
这项研究引入了一种针对腺三酸盐 (ATP) 的新型RNA干扰 (RNAi) 治疗,以抑制前列腺癌的生长. 该方法破坏细胞能量,导致癌细胞死亡和减少迁移.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 针对瘤能量代谢的化疗有效性有限.
- 腺三酸盐 (ATP) 对于细胞能量和瘤生长至关重要.
研究的目的:
- 开发和评估一种针对癌症治疗的ATP生产的RNA干扰 (RNAi) 策略.
- 调查ATP耗尽影响前列腺癌细胞的机制.
主要方法:
- 构建了一个干扰等离子体,表达一种ATP结合RNA的RNAi的RNAi.
- 评估了RNAi对细胞ATP水平,能量代谢 (糖解,氧化酸化),线粒体功能和前列腺癌细胞细胞迁移的影响.
- 分析了下游的信号通路,包括AMPK和ERK的酸化,拉美利波底形成,亡,血管生成和入侵.
主要成果:
- 向ATP的RNAi通过减少细胞质ATP的可用性和损害能量代谢,显著抑制前列腺癌细胞的生长.
- 抑制了糖解和氧化酸化.
- 破坏线粒体功能,减少线粒体数量,呼吸速率和膜潜力.
- 通过阻碍拉美利波形成,抑制细胞迁移.
- 下调AMPK和ERK的酸化,促进细胞亡,抑制血管生成和侵袭.
结论:
- 开发的RNAi模式是第一个针对和阻止ATP消耗的方法,为瘤治疗提供了一种新的方法.
- 这种方法有效地扰乱了细胞呼吸链和ATP池,为各种癌症提供了新的治疗策略.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
395
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
